Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00249639
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2005-11-03
Brief Title:
Contingency Management for Attendance - 2
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Contingency Management for Attendance
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness of a low-cost contingency management procedure as compared to standard treatment Using a cross-over design CM is implemented at different community-based clinics and compared with non-CM in the same facilities Research staff collects information regarding patients demographic characteristics attendance and outcomes at the clinics During Phase A non-CM standard clinical practice is in place During Phase B CM all patients have the chance to win prizes by coming to treatment Each participating clinic is randomly assigned to receive either the A or B phase first each phase is in effect for 16 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-16855-2 | None | None | None |